Real-time Estimate
Cboe BZX
02:46:08 2024-05-13 pm EDT
|
5-day change
|
1st Jan Change
|
23.85
USD
|
-0.58%
|
|
-2.29%
|
-10.40%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
825.8
|
1,049
|
1,114
|
855
|
694.3
|
631.4
|
-
|
-
|
Enterprise Value (EV)
1 |
1,018
|
1,259
|
1,380
|
1,208
|
1,098
|
1,089
|
1,136
|
1,182
|
P/E ratio
|
116
x
|
58.9
x
|
54.3
x
|
44.2
x
|
133
x
|
30.8
x
|
26.7
x
|
24
x
|
Yield
|
3.84%
|
3.58%
|
3.67%
|
4.93%
|
6.78%
|
7.71%
|
7.88%
|
8.05%
|
Capitalization / Revenue
|
13.6
x
|
13.9
x
|
12.3
x
|
8.75
x
|
6.15
x
|
5.09
x
|
4.62
x
|
4.03
x
|
EV / Revenue
|
16.7
x
|
16.6
x
|
15.2
x
|
12.4
x
|
9.73
x
|
8.78
x
|
8.32
x
|
7.54
x
|
EV / EBITDA
|
24.9
x
|
23.6
x
|
21.8
x
|
18.2
x
|
16.9
x
|
12
x
|
10.8
x
|
9.61
x
|
EV / FCF
|
-
|
147,627,274
x
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
19,268
|
22,265
|
23,567
|
23,883
|
26,061
|
26,321
|
-
|
-
|
Reference price
2 |
42.86
|
47.11
|
47.27
|
35.80
|
26.64
|
23.99
|
23.99
|
23.99
|
Announcement Date
|
2/25/20
|
2/16/21
|
2/15/22
|
2/14/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
60.85
|
75.68
|
90.58
|
97.68
|
112.8
|
124
|
136.5
|
156.7
|
EBITDA
1 |
40.9
|
53.3
|
63.36
|
66.27
|
64.79
|
90.5
|
105.3
|
123
|
EBIT
1 |
18.67
|
27.92
|
32.91
|
33.87
|
25.1
|
39.59
|
44.81
|
54.4
|
Operating Margin
|
30.68%
|
36.9%
|
36.33%
|
34.67%
|
22.24%
|
31.92%
|
32.82%
|
34.72%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
8.02
|
18.61
|
20.62
|
22.89
|
Net income
1 |
8.376
|
19.08
|
22.49
|
22.02
|
7.714
|
19.09
|
22.19
|
28.74
|
Net margin
|
13.77%
|
25.21%
|
24.83%
|
22.54%
|
6.84%
|
15.39%
|
16.25%
|
18.34%
|
EPS
2 |
0.3700
|
0.8000
|
0.8700
|
0.8100
|
0.2000
|
0.7800
|
0.9000
|
1.000
|
Free Cash Flow
|
-
|
8.527
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
11.27%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
16%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
44.7%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
1.645
|
1.685
|
1.735
|
1.765
|
1.805
|
1.850
|
1.890
|
1.930
|
Announcement Date
|
2/25/20
|
2/16/21
|
2/15/22
|
2/14/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
23.24
|
23.48
|
24.05
|
24.81
|
25.34
|
27.18
|
27.81
|
28.74
|
29.12
|
29.33
|
30.61
|
31.54
|
32.33
|
33.01
|
33.85
|
EBITDA
1 |
16.55
|
16.08
|
16.43
|
16.72
|
17.04
|
6.123
|
19.99
|
19.66
|
-
|
18.99
|
22.5
|
23.03
|
23.56
|
24.1
|
24.63
|
EBIT
1 |
8.727
|
8.132
|
8.3
|
8.715
|
8.72
|
-2.92
|
10.02
|
8.453
|
9.55
|
8.726
|
9.12
|
9.645
|
9.938
|
11.32
|
11.75
|
Operating Margin
|
37.55%
|
34.63%
|
34.51%
|
35.13%
|
34.41%
|
-10.74%
|
36.02%
|
29.42%
|
32.79%
|
29.75%
|
29.79%
|
30.58%
|
30.74%
|
34.28%
|
34.72%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
5.6
|
-
|
-
|
-6.887
|
6.627
|
3.713
|
4.567
|
3.665
|
4.492
|
4.732
|
4.927
|
4.793
|
5.231
|
Net income
1 |
6.113
|
5.524
|
5.584
|
5.673
|
5.238
|
-6.922
|
6.577
|
3.492
|
4.567
|
3.665
|
4
|
4.1
|
4.4
|
5.132
|
5.402
|
Net margin
|
26.3%
|
23.53%
|
23.22%
|
22.87%
|
20.67%
|
-25.47%
|
23.65%
|
12.15%
|
15.68%
|
12.49%
|
13.07%
|
13%
|
13.61%
|
15.55%
|
15.96%
|
EPS
2 |
0.2300
|
0.2100
|
0.2100
|
0.2100
|
0.1900
|
-0.3200
|
0.2400
|
0.1100
|
0.1500
|
0.1100
|
0.1900
|
0.2000
|
0.2100
|
0.2200
|
0.2200
|
Dividend per Share
2 |
0.4375
|
0.4400
|
0.4400
|
0.4425
|
0.4450
|
0.4475
|
0.4500
|
0.4525
|
0.4550
|
-
|
0.4600
|
0.4600
|
0.4700
|
0.4700
|
0.4700
|
Announcement Date
|
2/15/22
|
5/3/22
|
8/2/22
|
11/1/22
|
2/14/23
|
5/2/23
|
8/1/23
|
10/31/23
|
2/13/24
|
4/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
193
|
210
|
266
|
353
|
403
|
458
|
505
|
551
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.707
x
|
3.938
x
|
4.192
x
|
5.326
x
|
6.224
x
|
5.061
x
|
4.796
x
|
4.476
x
|
Free Cash Flow
|
-
|
8.53
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
7
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
9.24%
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/25/20
|
2/16/21
|
2/15/22
|
2/14/23
|
2/13/24
|
-
|
-
|
-
|
Last Close Price
23.99
USD Average target price
30
USD Spread / Average Target +25.05% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.40% | 631M | | +10.09% | 59.09B | | -4.96% | 19.25B | | +0.33% | 7.58B | | -10.80% | 5.82B | | +10.86% | 3.51B | | +1.44% | 3.36B | | -1.73% | 3.22B | | +11.30% | 2.87B | | +17.45% | 2.84B |
Healthcare REITs
|